AzTrials
AzTrials

Family ResearchNCT03796065

Addressing Mental Health Disparities in Refugee Children

A study testing FSI-R Treatment in people with Family Research, run by Boston College at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed study will employ a cross-cultural Community Based Participatory Research (CBPR) approach to build from prior needs assessments and mixed-methods research to evaluate the effectiveness of the Family Strengthening Intervention for Refugees (FSI-R), a preventative family home-based visiting intervention… Read more about this study

Who is it for?
Ages 7 years and older
Conditions the study is for
Family Research
What is being tested?
FSI-R Treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
354 participants
Where
2 sitesUnited States
Study dates
27 Aug 2018to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • being a resettled refugee family
  • having one or more school-aged children living in the home (aged 7-17)
  • be aged 18 or older
  • cares for and lives in the same household of the children at least 50% of the time
  • is the child'd legal guardian

Who cannot join

  • not meeting the above inclusion criteria
  • families in the midst of a crisis (e.g. active suicide attempts)

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Maine Immigrant and Refugee Services

    Lewiston, Maine, 04240

  • Jewish Family Service

    Springfield, Massachusetts, 01108

Other trials in United States

About this study

Official title: Addressing Mental Health Disparities in Refugee Children Through Family and Community-based Prevention: A CBPR Collaboration and Hybrid Implementation Effectiveness Trial

The proposed study will employ a cross-cultural Community Based Participatory Research (CBPR) approach to build from prior needs assessments and mixed-methods research to evaluate the effectiveness of the Family Strengthening Intervention for Refugees (FSI-R), a preventative family home-based visiting intervention intended to mitigate mental health disparities among refugee children and families using a hybrid implementation-effectiveness design. Results of the investigator's trial will expand the evidence-base on community-based interventions for refugees and has the potential to be replicated to reduce mental health disparities affecting diverse groups of refugee children and families.

Read the detailed description

Using a CBPR approach, a family based prevention model, the Family Strengthening Intervention for Refugees (FSI-R) was adapted from a tested model used in Africa and designed for delivery by refugee community health workers with through a process involving stakeholder consultation and local refugee Community Advisory Board input. Pilot data on the FSI-R demonstrates strong feasibility and acceptability, but further data are needed on effectiveness as well as barriers and facilitators to implementation by community health workers embedded in refugee-serving social services agencies. Specific aims are to (1) examine the impact of a family-based preventive intervention on outcomes of parent-child relationships, family functioning, and child mental health using a Hybrid Type 2 Effectiveness-Implementation Design (families with children aged 7-17 in a two-arm randomized controlled trial); (2) identify barriers and facilitators to implementation of the FSI-R by community health workers by conducting a process evaluation concurrent with the delivery of the intervention; and (3) strengthen the science of community engagement to address health disparities by fortifying CBPR-based pathways of change via collaborative partnerships between refugee communities, service providers, and academic stakeholders.

Conditions
Family Research
Being tested
FSI-R Treatment
Keywords
refugees, parental self-efficacy, family communication, family connectedness, refugee youth, youth functioning, integration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FSI-R TreatmentBehavioural

    Also called Family Strengthening Intervention for Refugees

    The FSI-R involves a series of separate and joint meetings with parents and children to discuss challenges the family has faced and the strengths that helped them make it through past challenging times. Additional psychoeducation on mental health and promoting resilience along with coaching to enhance parenting skills is provided throughout and may be tailored to family needs. The FSI-R provides a shared space for refugee families both to recognize their strengths and to problem-solve in a more collective way on family challenges and shared hopes for the future. The FSI-R is delivered in the home, by a trained interventionist, over the course of 10-modules.

Study groups in NCT03796065
Study groupRoleWhat they receive
FSI-R TreatmentExperimentalFamilies randomized into the FSI-R Treatment arm will receive the 10-module Family Strengthening Intervention in addition to any outside services or programs they are participating in.
Receives: Behavioral: FSI-R Treatment
FSI-R ControlNo interventionFamilies randomized into the FSI-R Control arm will not receive the FSI-R treatment. Instead, they will continue with their usual care, referred to as Treatment as Usual (TAU).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in conflict via the Family Conflict Scale

    The Family Conflict Scale utilizes a 7-point Likert Scale (0-6) to assess family conflict within the past month. Higher scores reflect greater family conflict.

    Measured: T1 (Baseline), T2 (approximately 24-months post-baseline), T3 (6-months follow-up from T2)

  2. Change in communication via the Revised Parent- Adolescent Communication Form

    Utilizes a 5-point Likert scale (1-5) to assess parent-child communication. Greater scores indicate higher communication between parents and their children.

    Measured: T1 (Baseline), T2 (approximately 24-months post-baseline), T3 (6-months follow-up from T2)

  3. Change in family conflict via the Intergenerational Conflict Index

    Utilizes a 5-point Likert scale (1-5) to assess intergenerational congruence across several domains of the parent-child relationship. Higher scores denote greater intergenerational congruence.

    Measured: T1 (Baseline), T2 (approximately 24-months post-baseline), T3 (6-months follow-up from T2)

  4. Change in parenting via the Alabama Parenting Questionnaire

    Likert scale (1-5) that includes 5 sub-domains. Each sub-domain results in a summed score that relates to 5 domains of parenting: involvement, positive parenting, poor monitoring/supervision, inconsistent discipline, and corporal punishment.

    Measured: T1 (Baseline), T2 (approximately 24-months post-baseline), T3 (6-months follow-up from T2)

Secondary outcomes (2)
  1. Change in youth externalizing behaviors via the African Youth Psychosocial Assessment

    This assessment utilizes a 4-point Likert scale (1-4) to assess for externalizing problems in youth with greater scores reflecting greater conduct problems.

    Measured: T1 (Baseline), T2 (approximately 24-months post-baseline), T3 (6-months follow-up from T2)

  2. Change in youth depression via the Center for Epidemiologic Studies-Depression scale

    This measures utilizes a 4-point Likert scale (0-3) to assess depression in youth with higher scores indicated increasing levels of depression. The time frame referenced is "during the past week".

    Measured: T1 (Baseline), T2 (approximately 24-months post-baseline), T3 (6-months follow-up from T2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2019
  2. Study start27 Aug 2018
  3. Primary completion30 Jun 2022
  4. Study completion30 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The investigators will conduct a Randomized Controlled Trial among Somali Bantu and Bhutanese families (N=300; 150 per group). Half of the families will be randomized to receive the FSI-R and half will be randomized to the control condition where the participants will receive Treatment as Usual (TAU).
Masking
Single blind
Who is masked
Care provider
Enrolment
354 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03796065
Sponsor's protocol ID
18.251.01
Status last verified
Feb 2023
First submitted
3 Jan 2019
Last updated
8 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Jung E, Black C, Placencio-Castro M, Chamlagai L, Osman R, Hoffman M, Beardslee W, Betancourt TS. Delivering a family-based child mental health promotion program among two resettled refugee communities during the COVID-19 pandemic: Lessons learned in a hybrid type II implementation-effectiveness randomized controlled trial. Am J Community Psychol. 2026 Mar;77(1-2):231-247. doi: 10.1002/ajcp.70021. Epub 2025 Oct 5.

    PubMed 41046558

Questions about this trial

What is this clinical trial studying?

A study testing FSI-R Treatment in people with Family Research, run by Boston College at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in conflict via the Family Conflict Scale (time frame: T1 (Baseline), T2 (approximately 24-months post-baseline), T3 (6-months follow-up from T2)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03796065, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in